As of December 2024, Iovance Biotherapeutics has a market cap of $2.00B. This makes Iovance Biotherapeutics the world's 5277th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $2.54B | 22.02% |
2023 | $2.08B | 27.23% |
2022 | $1.64B | -66.53% |
2021 | $4.89B | -58.86% |
2020 | $11.87B | 67.63% |
2019 | $7.08B | 212.77% |
2018 | $2.26B | 10.63% |
2017 | $2.05B | 15.11% |
2016 | $1.78B | -9.97% |
2015 | $1.98B | -1.91% |
2014 | $2.01B | -25.05% |
2013 | $2.69B | -52.27% |
2012 | $5.63B | -78.00% |
2011 | $25.59B | -20.00% |
2010 | $31.99B | - |